spotting on glp 1 For years, conventional wisdom held that skin improvements among patients GLP-1 medications were a byproduct of weight loss, which reduces inflammation. But doctors are a much more complex reality — Study: No Link Seen Between

A.WangZ.LevisonB

Improvement in insulin sensitivity The recent finding that GIP/GLP-1 receptor co-agonists like tirzepatide have superior efficacy compared to selective GLP-1 receptor agonists with respect to glycemic control as well as body weight has renewed interest in GIP [20], which previously was thought to be without any therapeutic potential

There's simply no formal data exploring how these three specific compounds interactwhether they work together synergistically or potentially cancel each other out

This article walks through what that evidence actually is, why no trial has started, and what would count as real progress